Clinical Trials Browser

Phase 1/2 × NIH × rucaparib × Clear all

NCT04209595 2025-03-17

PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers

Phase 1/2 Completed

10 enrolled 13 charts

Small Cell Lung Carcinoma